Yatiri Bio and Ordaōs Announce a Joint Development Agreement to Create Novel Therapeutics for AML  The Partnership will Interrogate Patient Proteome Data to Drive Drug Discovery for high-risk subsets of Acute Myeloid Leukemia (AML) SAN DIEGO, CA, December 15,…